<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJS</journal-id>
<journal-id journal-id-type="hwp">spijs</journal-id>
<journal-id journal-id-type="nlm-ta">Int J Surg Pathol</journal-id>
<journal-title>International Journal of Surgical Pathology</journal-title>
<issn pub-type="ppub">1066-8969</issn>
<issn pub-type="epub">1940-2465</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1066896911430959</article-id>
<article-id pub-id-type="publisher-id">10.1177_1066896911430959</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Rab11 Is a Useful Tool for the Diagnosis of Microvillous Inclusion Disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Talmon</surname><given-names>Geoffrey</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896911430959">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Holzapfel</surname><given-names>Melissa</given-names></name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="aff1-1066896911430959">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>DiMaio</surname><given-names>Dominick J.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896911430959">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Muirhead</surname><given-names>David</given-names></name>
<degrees>AIBMS, AIMLS, MSA</degrees>
<xref ref-type="aff" rid="aff1-1066896911430959">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1066896911430959"><label>1</label>University of Nebraska Medical Center, Omaha, NE, USA</aff>
<author-notes>
<corresp id="corresp1-1066896911430959">Geoffrey Talmon, Department of Pathology and Microbiology, University of Nebraska Medical Center, 983135 Nebraska Medical Center, Omaha, NE 68198-3135, USA Email: <email>gtalmon@unmc.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>6</month>
<year>2012</year>
</pub-date>
<volume>20</volume>
<issue>3</issue>
<fpage>252</fpage>
<lpage>256</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Microvillous inclusion disease (MVID) is a congenital condition presenting with intractable diarrhea. Biopsies demonstrate abnormal apical PAS and CD10 staining in surface enterocytes correlating with the presence of characteristic cytoplasmic inclusions. MVID has been linked to mutations in myosin Vb, important in apical membrane recycling. Rab11 associates with myosin Vb in vesicle membranes and is also integral in recycling plasma membrane components. The authors performed Rab11 immunostaining on biopsies from 7 MVID cases, 10 normal small intestines, and 10 with chronic enteritis. In MVID cases, Rab11 showed diffuse apical cytoplasmic staining of surface enterocytes in a pattern similar to PAS and CD10, which was absent in all the 20 control cases. Ultrastructural examination confirmed localization to the external surface of MVID cytoplasmic inclusions. Rab11 staining may be a useful adjunct in MVID diagnosis and the results support that myosin Vb dysfunction is important in the pathogenesis of MVID.</p>
</abstract>
<kwd-group>
<kwd>Rab11</kwd>
<kwd>microvillous inclusion disease</kwd>
<kwd>electron microscopy</kwd>
<kwd>myosin Vb</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1066896911430959" sec-type="intro">
<title>Introduction</title>
<p>Microvillous inclusion disease (MVID), also known as microvillous atrophy, is a rare congenital condition caused by a defect in enterocytes leading to protracted diarrhea, typically presenting within the first days of life, which does not respond to bowel rest.<sup><xref ref-type="bibr" rid="bibr1-1066896911430959">1</xref><xref ref-type="bibr" rid="bibr2-1066896911430959"/>-<xref ref-type="bibr" rid="bibr3-1066896911430959">3</xref></sup> Survival usually depends on early institution of total parenteral nutrition and prolonged survival requires intestinal transplantation in most cases.<sup><xref ref-type="bibr" rid="bibr3-1066896911430959">3</xref></sup></p>
<p>Small intestinal mucosal biopsies from patients with MVID reveal variable villous blunting, often without crypt hyperplasia. There is typically replacement of the normal crisp staining of the surface enterocyte brush border with periodic acid Schiff (PAS) and CD10 by diffuse apical cytoplasmic reactivity.<sup><xref ref-type="bibr" rid="bibr3-1066896911430959">3</xref></sup> Ultrastructural examination, widely considered the gold standard for diagnosis, shows membrane-bound inclusions containing microvilli in the apical portion of enterocytes with an associated loss/ disorganization of surface microvilli.<sup><xref ref-type="bibr" rid="bibr3-1066896911430959">3</xref>,<xref ref-type="bibr" rid="bibr4-1066896911430959">4</xref></sup></p>
<p>A subset of MVID cases is inherited in an autosomal recessive fashion. A kindred of Navajo patients with MVID has been found to harbor mutations in MYO5B.<sup><xref ref-type="bibr" rid="bibr5-1066896911430959">5</xref><xref ref-type="bibr" rid="bibr6-1066896911430959"/>-<xref ref-type="bibr" rid="bibr7-1066896911430959">7</xref></sup> This gene encodes for myosin Vb,<sup><xref ref-type="bibr" rid="bibr6-1066896911430959">6</xref></sup> a so-called “unconventional” myosin that is associated with plasma membrane recycling in epithelial cells.<sup><xref ref-type="bibr" rid="bibr8-1066896911430959">8</xref></sup> This motor protein is known to functionally interact with a variety of proteins, notably including members of the Rab family of the Ras superfamily of monomeric G-proteins.<sup><xref ref-type="bibr" rid="bibr6-1066896911430959">6</xref>,<xref ref-type="bibr" rid="bibr7-1066896911430959">7</xref>,<xref ref-type="bibr" rid="bibr9-1066896911430959">9</xref></sup> This family is involved in the regulation of endosome-mediated plasma membrane recycling.<sup><xref ref-type="bibr" rid="bibr6-1066896911430959">6</xref>,<xref ref-type="bibr" rid="bibr10-1066896911430959">10</xref>,<xref ref-type="bibr" rid="bibr11-1066896911430959">11</xref></sup></p>
<p>In this study, we describe the immunoperoxidase staining pattern of Rab11 in the small intestinal mucosa of patients with MVID and contrast it with the patterns seen in normal small intestinal mucosa. In addition, the localization of Rab11 reactivity is correlated with ultrastructural localization of the protein with immunogold staining. The findings suggest that Rab11 may be a useful adjunct to MVID diagnosis in facilities without electron microscopy capabilities.</p>
</sec>
<sec id="section2-1066896911430959" sec-type="methods">
<title>Methods</title>
<p>Slides from endoscopic small intestinal biopsies or segmental resections from 7 patients with ultrastructurally confirmed MVID were obtained from the files of the Pathology Department of the University of Nebraska Medical Center. The clinical history for each patient was reviewed. Similar material from endoscopic mucosal biopsies of 10 normal pediatric small intestines and 10 demonstrating chronic enteritis (patient with a history of chronic inflammatory bowel disease demonstrating villous blunting with or without crypt hyperplasia and an increase in lamina propria chronic inflammatory cells) were retrieved. Hematoxylin and eosin (H&amp;E), PAS, and CD10 stains were examined.</p>
<p>Rab11 immunoperoxidase staining was performed on each case. Five-micrometer thick sections of formalin-fixed, paraffin-embedded tissue were pretreated with high pH TRS (target retrieval solution; Dako, Carpenteria, CA) and incubated for 30 minutes using mouse monoclonal antibodies against Rab11 (BD Biosciences, San Diego, CA) at a dilution of 1:100.</p>
<p>Resin-embedded blocks from a representative case of MVID were obtained. Multiple 1-µm thick sections were stained with 1% toluidine blue in borax and examined. A representative block was selected and ultrasection at 80 nm (silver sections) mounted on nickel 300 mesh grids, and treated with 0.1 M sodium citrate and 0.5 M NH<sub>4</sub>Cl. The grids were incubated with AURION goat blocking buffer (Wageningen, the Netherlands) and underwent an overnight incubation with a Rab11 antibody dilution (1:25) followed by a 2-hour treatment with 1:40 dilution of a solution containing AURION goat anti-mouse IgG/IgM antibody complexed with 10 nm gold particles. The sections were then post fixed in 2% glutaraldehyde, stained with uranyl acetate/lead citrate, and viewed on a JEOL 1230 transmission electron microscope. Representative electron micrographs were taken.</p>
</sec>
<sec id="section3-1066896911430959" sec-type="results">
<title>Results</title>
<p>Each patient with MVID presented shortly following birth with protracted diarrhea (“early onset”) and underwent intestinal transplantation. Three patients were siblings.</p>
<p>By H&amp;E staining, all cases of MVID displayed villous blunting with variable degrees of crypt hyperplasia. There was no significant increase in intraepithelial inflammatory cells and active inflammation could not be identified. PAS and CD10 stains on each of the 20 control cases showed crisp staining of the brush border of the epithelial cells at all levels of the mucosa. In the MVID cases, there was a loss of the staining pattern with surface epithelial cells showing apical cytoplasmic staining instead (<xref ref-type="fig" rid="fig1-1066896911430959">Figures 1</xref> and <xref ref-type="fig" rid="fig2-1066896911430959">2</xref>).</p>
<fig id="fig1-1066896911430959" position="float">
<label>Figure 1.</label>
<caption><p>Small intestinal mucosal biopsy from a patient with microvillous inclusion disease (MVID) stained with periodic acid Schiff (PAS). The normal crisp brush border staining of surface enterocytes is replaced by a diffuse apical cytoplasmic blush (100×)</p></caption>
<graphic xlink:href="10.1177_1066896911430959-fig1.tif"/>
</fig>
<fig id="fig2-1066896911430959" position="float">
<label>Figure 2.</label>
<caption><p>A CD10 immunoperoxidase stain from the same patient as <xref ref-type="fig" rid="fig1-1066896911430959">Figure 1</xref>, demonstrating a similar staining pattern as with periodic acid Schiff (PAS; 100×)</p></caption>
<graphic xlink:href="10.1177_1066896911430959-fig2.tif"/>
</fig>
<p>Rab11 immunostaining showed a similar staining pattern to PAS and CD10 in each of the seven MVID cases with diffuse apical cytoplasmic staining in enterocytes at all levels of the mucosa (<xref ref-type="fig" rid="fig3-1066896911430959">Figure 3</xref>). Rab11 showed variable apical cytoplasmic staining in crypt cells in 8 of the normal and 9 of the chronic enteritis biopsies with the rest being completely negative. In 5 of the normal biopsies and 2 with chronic enteritis, the staining was barely perceptible in only the deepest portions of the crypts. The remainder (3 normal, 7 chronic enteritis) showed stronger apical crypt staining that transitioned to a weak diffuse cytoplasmic blush in high crypt/low villous epithelial cells (<xref ref-type="fig" rid="fig4-1066896911430959">Figure 4</xref>). Surface epithelial cells were negative in all 20 control cases.</p>
<fig id="fig3-1066896911430959" position="float">
<label>Figure 3.</label>
<caption><p>Rab11 immuoperoxidase staining from a patient with microvillous inclusion disease (MVID). Note that the staining pattern is identical to that seen with periodic acid Schiff (PAS) and CD10 (100×)</p></caption>
<graphic xlink:href="10.1177_1066896911430959-fig3.tif"/>
</fig>
<fig id="fig4-1066896911430959" position="float">
<label>Figure 4.</label>
<caption><p>Rab11 in a small bowel biopsy from unaffected patient with chronic enteritis that shows somewhat stronger staining. Note the apical staining in the crypt epithelial cells (long arrow) that transitions to a diffuse cytoplasmic blush in the low villous epithelium (short arrow). The surface epithelium is negative (asterisk; 100×)</p></caption>
<graphic xlink:href="10.1177_1066896911430959-fig4.tif"/>
</fig>
<p>The representative case of MVID examined by electron microscopy demonstrated ultrastructural disorganization and loss of microvilli at the enterocyte luminal surface with cells containing abundant prototypic apical cytoplasmic inclusions. Rab11 immunogold labeling showed localization of 10 nm gold particles in association with the membrane of the inclusions and at the base of the luminal surface (<xref ref-type="fig" rid="fig5-1066896911430959">Figure 5</xref>).</p>
<fig id="fig5-1066896911430959" position="float">
<label>Figure 5.</label>
<caption><p>Transmission electron micrograph showing gold-labeled Rab11 antibodies (short arrows) localized around the membrane of an apical inclusion containing microvilli (asterisk). Note the disordered brush border (long arrow; 2500×)</p></caption>
<graphic xlink:href="10.1177_1066896911430959-fig5.tif"/>
</fig>
</sec>
<sec id="section4-1066896911430959" sec-type="discussion">
<title>Discussion</title>
<p>MVID is a rare life-threatening condition that presents early in life with profuse, intractable diarrhea. Affected patients are dependent on parenteral nutrition for survival and without intestinal transplantation they often succumb to complications of central venous access or cholestatic liver disease.<sup><xref ref-type="bibr" rid="bibr3-1066896911430959">3</xref>,<xref ref-type="bibr" rid="bibr5-1066896911430959">5</xref>,<xref ref-type="bibr" rid="bibr8-1066896911430959">8</xref></sup></p>
<p>The pathogenesis of the disease has not been completely elucidated. When MVID was first described, it was felt to represent abnormal assembly of the microvilli.<sup><xref ref-type="bibr" rid="bibr3-1066896911430959">3</xref>,<xref ref-type="bibr" rid="bibr12-1066896911430959">12</xref></sup> Later case series with descriptions of ultrastructural findings led others to theorize that the condition was the result of endocytosis of the apical enterocyte surface.<sup><xref ref-type="bibr" rid="bibr12-1066896911430959">12</xref>,<xref ref-type="bibr" rid="bibr13-1066896911430959">13</xref></sup></p>
<p>Molecular genetic analysis has shed light on MVID’s mechanism. A subset of MVID cases has been known to occur familially and noted to follow an autosomal recessive inheritance pattern in certain kindreds.<sup><xref ref-type="bibr" rid="bibr5-1066896911430959">5</xref><xref ref-type="bibr" rid="bibr6-1066896911430959"/>-<xref ref-type="bibr" rid="bibr7-1066896911430959">7</xref></sup> It has been linked to abnormalities in MYO5B,<sup><xref ref-type="bibr" rid="bibr6-1066896911430959">6</xref>,<xref ref-type="bibr" rid="bibr7-1066896911430959">7</xref></sup> a gene that encodes for myosin Vb. Molecular analysis from a series of 11 unrelated patients with early-onset MVID has shown that mutations in MYO5B are frequent. An in vitro MYO5B knock down intestinal epithelial cell model showed a recapitulation of the ultrastructural MVID findings.<sup><xref ref-type="bibr" rid="bibr5-1066896911430959">5</xref></sup> These lines of evidence support that MVID loss of function of myosin Vb and/or other elements of the apical membrane traffic pathway(s) in which it participates.</p>
<p>Class V myosins are motor proteins that are involved in vesicle transport in numerous human cell types. Myosin Va is seen in melanocytes and neurons<sup><xref ref-type="bibr" rid="bibr8-1066896911430959">8</xref></sup> with defects in the protein’s function being seen in Griscelli syndrome.<sup><xref ref-type="bibr" rid="bibr14-1066896911430959">14</xref></sup> Myosin Vb is predominately expressed in intestinal tissue.<sup><xref ref-type="bibr" rid="bibr5-1066896911430959">5</xref></sup> It is involved in plasma membrane recycling systems, particularly active in apical recycling of polarized cells.<sup><xref ref-type="bibr" rid="bibr8-1066896911430959">8</xref></sup> Such mechanisms are critical to the maintenance of normal cell membrane composition and architecture. Specifically, the “unconventional” myosin Vb appears to be needed for transit of vesicles and materials out of the recycling pathways.<sup><xref ref-type="bibr" rid="bibr8-1066896911430959">8</xref>,<xref ref-type="bibr" rid="bibr11-1066896911430959">11</xref></sup> One study showed not only that the inclusions were likely derived from autophagocytosis but also that the inclusions lacked lysosome-associated membrane protein, supporting that these MVID inclusions do not represent early endosomes or lysosomes.<sup><xref ref-type="bibr" rid="bibr13-1066896911430959">13</xref></sup></p>
<p>Several studies have shown that members of the Rab11 family of guanosine triphosphate (GTP)-binding proteins are also critical components in membrane recycling.<sup><xref ref-type="bibr" rid="bibr11-1066896911430959">11</xref></sup> The proteins are believed to mediate transport vesicle budding, shuttling within the cytoplasm, and fusion with downstream components.<sup><xref ref-type="bibr" rid="bibr10-1066896911430959">10</xref></sup> In association with coupling proteins, such as Rab11–FIP2,<sup><xref ref-type="bibr" rid="bibr10-1066896911430959">10</xref></sup> Rab11 is involved in linking membrane bound vesicles to myosin Vb.<sup><xref ref-type="bibr" rid="bibr14-1066896911430959">14</xref></sup> Indeed, the Rab11–FIP2 complex has proven to be necessary for transferrin recycling to the cell surface in HeLa cell lines with the complex being formed after Rab11 interaction with the vesicle.<sup><xref ref-type="bibr" rid="bibr10-1066896911430959">10</xref></sup></p>
<p>Our hypothesis was that the mechanism of MVID centers on a defect in apical enterocyte plasma membrane recycling following endocytosis. Based on the above evidence, vesicles that leave recycling endosomes bound for reapplication to the cell membrane should have Rab11 on their external surface. Immunohistochemistry using anti-Rab11 antibodies would label the external surface of the accumulated MVID inclusions and show a similar staining pattern to CD10 and PAS that highlight elements of the brush border.<sup><xref ref-type="bibr" rid="bibr15-1066896911430959">15</xref></sup></p>
<p>All 7 cases of early-onset MVID showed strong diffuse apical cytoplasmic staining for Rab11 staining in surface enterocytes similar to that seen with PAS and CD10. In each of the control cases, this pattern was not observed. By electron microscopy, gold-tagged Rab11 antibodies were confirmed that the external surface of microvilli-containing inclusion membrane and cytoplasmic face of the cell membrane at or near the terminal web.</p>
<p>Clinicopathologic surveys have highlighted that MVID has 2 phenotypes: children who present within days of birth (“early onset”) or the first months of life (“late onset”),<sup><xref ref-type="bibr" rid="bibr5-1066896911430959">5</xref>,<xref ref-type="bibr" rid="bibr12-1066896911430959">12</xref></sup> the latter being much less common and having a somewhat better prognosis.<sup><xref ref-type="bibr" rid="bibr12-1066896911430959">12</xref>,<xref ref-type="bibr" rid="bibr16-1066896911430959">16</xref></sup> In late-onset MVID, PAS staining abnormalities have been described as starting in enterocytes higher in the mucosa than early onset (low villous epithelium vs high crypt).<sup><xref ref-type="bibr" rid="bibr12-1066896911430959">12</xref>,<xref ref-type="bibr" rid="bibr16-1066896911430959">16</xref></sup> In keeping with our theory as to MVID’s mechanism, the defects in plasma membrane recycling systems may be less pronounced in late onset cases (either because of a lesser decrease in myosin Vb function or because of mutation in another gene in the pathway). This may explain why the staining abnormality is present in cells that are more mature and the clinical phenotype is not as severe. All cases of MVID in our series were early onset, demonstrating apical cytoplasmic Rab11 reactivity at all levels of the mucosa. It may prove interesting to see if there is any difference in the staining pattern in late-onset cases.</p>
<p>In conclusion, we describe the immunoperoxidase staining results of Rab11 in small bowel mucosal biopsies from patients with MVID, a pattern identical to that seen with PAS and CD10. Electron microscopy confirms that the antigen is present on the outer membrane surface of the characteristic inclusions. In our small series, the stain appears to be specific for the condition and may prove to be a useful diagnostic adjunct. Furthermore, the results support that MVID is a defect in apical plasma membrane recycling systems.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<p>The author(s) received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1066896911430959">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ruemmele</surname><given-names>FM</given-names></name>
<name><surname>Scmitz</surname><given-names>J</given-names></name>
<name><surname>Goulet</surname><given-names>O</given-names></name>
</person-group>. <article-title>Microvillous inclusion disease (microvillous atrophy)</article-title>. <source>Orphanet J Rare Dis</source>. <year>2006</year>;<volume>1</volume>:<fpage>22</fpage>-<lpage>26</lpage>.</citation>
</ref>
<ref id="bibr2-1066896911430959">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cutz</surname><given-names>E</given-names></name>
<name><surname>Rhoads</surname><given-names>M</given-names></name>
<name><surname>Drumm</surname><given-names>B</given-names></name>
<name><surname>Sherman</surname><given-names>PM</given-names></name>
<name><surname>Durie</surname><given-names>PR</given-names></name>
<name><surname>Forstner</surname><given-names>GG</given-names></name>
</person-group>. <article-title>Microvillus inclusion disease: an inherited defect of brush border assembly and differentiation</article-title>. <source>N Engl J Med</source>. <year>1989</year>;<volume>320</volume>:<fpage>646</fpage>-<lpage>651</lpage>.</citation>
</ref>
<ref id="bibr3-1066896911430959">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rund</surname><given-names>CR</given-names></name>
<name><surname>Carmichael</surname><given-names>B</given-names></name>
<name><surname>Harris</surname><given-names>AA</given-names></name>
<name><surname>Schaffner</surname><given-names>V</given-names></name>
</person-group>. <article-title>Small bowel biopsy in a 6-week-old infant</article-title>. <source>Arch Pathol Lab Med</source>. <year>2006</year>;<volume>130</volume>:<fpage>e19</fpage>-<lpage>e21</lpage>.</citation>
</ref>
<ref id="bibr4-1066896911430959">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Koepsell</surname><given-names>SA</given-names></name>
<name><surname>Talmon</surname><given-names>G</given-names></name>
</person-group>. <article-title>Light microscopic diagnosis of microvillus inclusion disease on colorectal specimens using CD10</article-title>. <source>Am J Surg Pathol</source>. <year>2010</year>;<volume>34</volume>:<fpage>970</fpage>-<lpage>972</lpage>.</citation>
</ref>
<ref id="bibr5-1066896911430959">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ruemmele</surname><given-names>FM</given-names></name>
<name><surname>Müller</surname><given-names>T</given-names></name>
<name><surname>Schiefermeier</surname><given-names>N</given-names></name>
<etal/>
</person-group>. <article-title>Loss-of-function of MYO5B is the main cause of microvillus inclusion disease: 15 novel mutations and a CaCo-2 RNAi cell model</article-title>. <source>Hum Mutat</source>. <year>2010</year>;<volume>31</volume>:<fpage>544</fpage>-<lpage>551</lpage>.</citation>
</ref>
<ref id="bibr6-1066896911430959">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Erickson</surname><given-names>RP</given-names></name>
<name><surname>Larson-Thome</surname><given-names>K</given-names></name>
<name><surname>Valenzuela</surname><given-names>RK</given-names></name>
<name><surname>Whitaker</surname><given-names>SE</given-names></name>
<name><surname>Shub</surname><given-names>MD</given-names></name>
</person-group>. <article-title>Navajo microvillous inclusion disease is due to a mutation in MYO5B</article-title>. <source>Am J Med Genet</source>. <year>2008</year>;<volume>146A</volume>:<fpage>3117</fpage>-<lpage>3119</lpage>.</citation>
</ref>
<ref id="bibr7-1066896911430959">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Müller</surname><given-names>T</given-names></name>
<name><surname>Hess</surname><given-names>MW</given-names></name>
<name><surname>Schiefermeier</surname><given-names>N</given-names></name>
<etal/>
</person-group>. <article-title>MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarity</article-title>. <source>Nat Genet</source>. <year>2008</year>;<volume>40</volume>:<fpage>1163</fpage>-<lpage>1165</lpage>.</citation>
</ref>
<ref id="bibr8-1066896911430959">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lapierre</surname><given-names>LA</given-names></name>
<name><surname>Kumar</surname><given-names>R</given-names></name>
<name><surname>Hales</surname><given-names>CM</given-names></name>
<etal/>
</person-group>. <article-title>Myosin Vb is associated with plasma membrane recycling systems</article-title>. <source>Mol Biol Cell</source>. <year>2001</year>;<volume>12</volume>:<fpage>1843</fpage>-<lpage>1857</lpage>.</citation>
</ref>
<ref id="bibr9-1066896911430959">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stenmark</surname><given-names>H</given-names></name>
<name><surname>Olkkonen</surname><given-names>VM</given-names></name>
</person-group>. <article-title>The Rab GTPase family</article-title>. <source>Genome Biol</source>. <year>2001</year>;<volume>2</volume>:<fpage>3007</fpage>.</citation>
</ref>
<ref id="bibr10-1066896911430959">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lindsay</surname><given-names>AJ</given-names></name>
<name><surname>McCaffrey</surname><given-names>MW</given-names></name>
</person-group>. <article-title>Rab11-FIP2 functions in transferring recycling and associates with endosomal membranes via its COOH-terminal domain</article-title>. <source>J Biol Chem</source>. <year>2002</year>;<volume>277</volume>:<fpage>27193</fpage>-<lpage>27199</lpage>.</citation>
</ref>
<ref id="bibr11-1066896911430959">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Grant</surname><given-names>BD</given-names></name>
<name><surname>Donaldson</surname><given-names>JG</given-names></name>
</person-group>. <article-title>Pathways and mechanisms of endocytic recycling</article-title>. <source>Nat Rev Mol Cell Biol</source>. <year>2009</year>;<volume>10</volume>: <fpage>597</fpage>-<lpage>608</lpage>.</citation>
</ref>
<ref id="bibr12-1066896911430959">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Phillips</surname><given-names>AD</given-names></name>
<name><surname>Schmitz</surname><given-names>J</given-names></name>
</person-group>. <article-title>Familial microvillous atrophy: a clinicopathological survey of 23 cases</article-title>. <source>J Pediatr Gastroenterol Nutr</source>. <year>1992</year>;<volume>14</volume>:<fpage>380</fpage>-<lpage>396</lpage>.</citation>
</ref>
<ref id="bibr13-1066896911430959">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Reishagen</surname><given-names>K</given-names></name>
<name><surname>Naim</surname><given-names>HY</given-names></name>
<name><surname>Zimmer</surname><given-names>KP</given-names></name>
</person-group>. <article-title>Autophagocytosis of the apical membrane in microvillus inclusion disease</article-title>. <source>Gut</source>. <year>2002</year>;<volume>51</volume>:<fpage>514</fpage>-<lpage>521</lpage>.</citation>
</ref>
<ref id="bibr14-1066896911430959">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Goud</surname><given-names>B</given-names></name>
</person-group>. <article-title>How Rab proteins link motors to membranes</article-title>. <source>Nat Cell Biol</source>. <year>2002</year>;<volume>4</volume>:<fpage>E77</fpage>-<lpage>E78</lpage>.</citation>
</ref>
<ref id="bibr15-1066896911430959">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Groisman</surname><given-names>GM</given-names></name>
<name><surname>Amar</surname><given-names>M</given-names></name>
<name><surname>Livine</surname><given-names>E</given-names></name>
</person-group>. <article-title>CD10: a valuable tool for the light microscopic diagnosis of microvillous inclusion disease (familial microvillous atrophy)</article-title>. <source>Am J Surg Pathol</source>. <year>2002</year>;<volume>26</volume>:<fpage>902</fpage>-<lpage>907</lpage>.</citation>
</ref>
<ref id="bibr16-1066896911430959">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Croft</surname><given-names>NM</given-names></name>
<name><surname>Howatson</surname><given-names>AG</given-names></name>
<name><surname>Ling</surname><given-names>SC</given-names></name>
<name><surname>Nairn</surname><given-names>L</given-names></name>
<name><surname>Evans</surname><given-names>TJ</given-names></name>
<name><surname>Weaver</surname><given-names>LT</given-names></name>
</person-group>. <article-title>Microvillous inclusion disease: an evolving condition</article-title>. <source>J Pediatr Gastroenterol Nutr</source>. <year>2000</year>;<volume>31</volume>:<fpage>185</fpage>-<lpage>189</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>